Abbott Laboratories (ABT) Amortization of Deferred Charges (2017 - 2018)

Abbott Laboratories (ABT) reported Amortization of Deferred Charges of $32.0 million for Q1 2018, down 91.84% on a YoY basis from $392.0 million in Q1 2017, and down 52.24% sequentially from $67.0 million in Q4 2017.

Abbott Laboratories (ABT) Amortization of Deferred Charges (2017 - 2018) Analysis & Trends

Abbott Laboratories (ABT) has 2 years of Amortization of Deferred Charges data on file, last reported at $32.0 million in Q1 2018.

  • For the quarter ending Q1 2018, Amortization of Deferred Charges fell 91.84% year-over-year to $32.0 million; the trailing twelve-month figure through Dec 2018 stood at $32.0 million (down 96.48% YoY), and the FY2018 full-year result was $32.0 million, down 96.47% from the prior year.
  • Amortization of Deferred Charges eased to $32.0 million in Q1 2018, from $67.0 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $430.0 million in Q2 2017 to a low of $20.0 million in Q3 2017.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2018 32.00 Mn
Mar 31, 2018 32.00 Mn
Dec 31, 2017 67.00 Mn
Dec 31, 2017 67.00 Mn
Sep 30, 2017 20.00 Mn
Sep 30, 2017 20.00 Mn
Jun 30, 2017 430.00 Mn
Jun 30, 2017 430.00 Mn
Mar 31, 2017 392.00 Mn
Mar 31, 2017 392.00 Mn